Targeting MDSCs using ATRA: a phase I/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma
Work
Year: 2021
Type: preprint
Abstract: Myeloid-derived suppressor cells (MDSCs) are potent suppressors of antitumor immunity and are commonly associated with poor outcomes in melanoma patients treated with immune checkpoint inhibitors. In... more
Authors Richard P. Tobin, Dasha T. Cogswell, Victoria M. Vorwald, Dana M. Davis, Jessica S.W. Borgers +11 more
Cites: 36
Cited by: 1
Related to: 10
Citation percentile (by year/subfield): 59.38
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green